Latest Insider Transactions at Avidity Biosciences, Inc. (RNA)
This section provides a real-time view of insider transactions for Avidity Biosciences, Inc. (RNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avidity Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avidity Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+1.63%
|
$900
$1.24 P/Share
|
|
Jan 20
2023
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+49.82%
|
-
|
|
Jan 20
2023
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.38%
|
-
|
|
Jan 20
2023
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+48.83%
|
-
|
|
Jan 20
2023
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,500
+45.85%
|
-
|
|
Jan 20
2023
|
Arthur A Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+48.22%
|
-
|
|
Jan 12
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
10,000
-88.26%
|
$220,000
$22.0 P/Share
|
|
Jan 12
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+46.88%
|
$10,000
$1.24 P/Share
|
|
Dec 29
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
40,000
-96.78%
|
$880,000
$22.01 P/Share
|
|
Dec 29
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+49.18%
|
$40,000
$1.24 P/Share
|
|
Aug 25
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
14,855
-100.0%
|
$341,665
$23.07 P/Share
|
|
Aug 25
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,855
+50.0%
|
$14,855
$1.24 P/Share
|
|
Aug 24
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
35,045
-100.0%
|
$770,990
$22.8 P/Share
|
|
Aug 24
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,045
+50.0%
|
$35,045
$1.24 P/Share
|
|
Aug 16
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
3,499
-72.46%
|
$76,978
$22.08 P/Share
|
|
Aug 16
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,499
+42.01%
|
$3,499
$1.24 P/Share
|
|
Aug 15
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
62,498
-97.92%
|
$1,374,956
$22.12 P/Share
|
|
Aug 15
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62,498
+42.04%
|
$0
$0.89 P/Share
|
|
Aug 15
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$2,200
$22.47 P/Share
|
|
Aug 15
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$100
$1.24 P/Share
|
|
Aug 12
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
14,003
-91.33%
|
$308,066
$22.0 P/Share
|
|
Aug 12
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,003
+47.73%
|
$0
$0.53 P/Share
|
|
Nov 18
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
25,000
-94.95%
|
$675,000
$27.89 P/Share
|
|
Nov 18
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.46%
|
$0
$0.89 P/Share
|
|
Aug 04
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
800,000
+14.3%
|
$14,400,000
$18.0 P/Share
|
|
Jun 25
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
20,100
-74.0%
|
$562,800
$28.55 P/Share
|
|
Jun 25
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,100
+30.35%
|
$0
$0.89 P/Share
|
|
Jun 24
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
100
-6.99%
|
$2,700
$27.75 P/Share
|
|
Jun 24
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+6.54%
|
$100
$1.24 P/Share
|
|
Jun 17
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
200
-13.07%
|
$5,400
$27.75 P/Share
|
|
Jun 17
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+11.56%
|
$200
$1.24 P/Share
|
|
Jun 15
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
23,019
-100.0%
|
$598,494
$26.02 P/Share
|
|
Jun 14
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
14,003
-37.82%
|
$350,075
$25.92 P/Share
|
|
Mar 16
2021
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
4,600
-100.0%
|
$124,200
$27.87 P/Share
|
|
Mar 16
2021
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+40.02%
|
$0
$0.89 P/Share
|
|
Mar 05
2021
|
Arthur A Levin Director |
BUY
Bona fide gift
|
Indirect |
37,022
+50.0%
|
-
|
|
Mar 05
2021
|
Arthur A Levin Director |
SELL
Bona fide gift
|
Indirect |
37,022
-11.91%
|
-
|
|
Dec 22
2020
|
Troy Edward Wilson Director |
BUY
Other acquisition or disposition
|
Indirect |
100,000
+50.0%
|
-
|
|
Dec 22
2020
|
Troy Edward Wilson Director |
SELL
Other acquisition or disposition
|
Direct |
100,000
-52.74%
|
-
|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
300,000
+10.66%
|
$5,400,000
$18.0 P/Share
|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
2,214,545
+50.0%
|
-
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+19.21%
|
$17,100,000
$18.0 P/Share
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,045,000
+50.0%
|
-
|
|
Jun 16
2020
|
Lilly & CO Eli |
BUY
Conversion of derivative security
|
Direct |
2,169,396
+50.0%
|
-
|